BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management

  July 7, 2026

   · 

  4 min read
• Press Releases

  BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™

  July 7, 2026

   · 

  3 min read
• Press Releases

  Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026

  July 7, 2026

   · 

  5 min read
• Press Releases

  Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026

  July 7, 2026

   · 

  7 min read
• Press Releases

  KIFFIK Biomedical Appoints Dr. Mark Vreeke as Chief Technology Officer

  July 7, 2026

   · 

  3 min read
• Press Releases

  DemeRx Strengthens Leadership Team With Appointment of Biopharmaceutical Executive Michael Snitkovsky as Chief Operations Officer

  July 7, 2026

   · 

  3 min read
• 

  Mergers & acquisitions

  Vertex inks $10B Crinetics buy, entering ‘white space blockbuster opportunity’

  Vertex Pharmaceuticals’ acquisition of Crinetics Pharmaceuticals is the largest pickup in the company’s history, according to analysts at BMO Capital Markets.

  July 7, 2026

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Spur Therapeutics Announces First Patient Dosed in GALILEO-3 Pivotal Clinical Trial of FLT201 for the Treatment of Gaucher Disease Type 1

  July 7, 2026

   · 

  3 min read
• Press Releases

  Breakthrough T1D Awards Grant to Support PRISE‑hATG Study of SAB‑142 in Stage 3 Type 1 Diabetes

  July 7, 2026

   · 

  6 min read
• Press Releases

  Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization

  July 7, 2026

   · 

  11 min read